Belite Bio (BLTE) Shares Outstanding (2020 - 2026)

Belite Bio's Shares Outstanding history runs 7 years deep, the most recent figure standing at $40.1 billion for Q1 2026.

• In Q1 2026, Shares Outstanding rose 23.16% year-over-year to $40.1 billion; the TTM figure through Mar 2026 stood at $40.1 billion (up 23.16% YoY), while the FY2025 annual figure was $39.4 million, up 23.65% from the prior year.
• Shares Outstanding was $40.1 billion for Q1 2026 at Belite Bio, up from $39.4 billion in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $400.0 billion in Q1 2023 to a low of $24.9 million in Q4 2022.
• Historically, Shares Outstanding has averaged $314.3 billion across 5 years, with a median of $400.0 billion in 2023.
• Biggest YoY gain for Shares Outstanding was 123549.49% in 2025; the steepest drop was 6.47% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $24.9 million in 2022, then advanced by 17.07% to $29.1 million in 2023, then grew by 9.18% to $31.8 million in 2024, then jumped by 123549.49% to $39.4 billion in 2025, then advanced by 2.01% to $40.1 billion in 2026.
• The last three Shares Outstanding figures came in at $40.1 billion (Q1 2026), $39.4 billion (Q4 2025), and $34.9 billion (Q3 2025), per Business Quant data.